Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study BioPharma Dive Source link
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution The Globe and Mail Source link